Sequencing cancer genomes to tailor treatments to individual patients Screening for hundreds of mutations in tumours is the most promising route to customised drug treatments for cancer.…
EU and US criticise Russia over protectionist measures for its pharmaceutical industry The European Union (EU) and the United States have criticised Russia’s move away from open trade and introduction of policies that discriminate against foreign imports, including pharmaceuticals and medical devices.…
Exploring the history of generic medicines ‘Generic: the unbranding of modern medicine’ by Jeremy A Greene.…
Medicinal cannabis: time for a comeback? The stringent laws on cannabis do no favours for patients, clinicians and researchers.…
Smartphones help to improve medicine adherence in teenagers and young adults Half of teenagers and young adults with kidney disease have used smartphones to help them remember to take their medicines, a study suggests.…
Forces driving the evolution of biologics into biosimilars and biobetters As demand for biologics increases, manufacturers are devising strategies to maximise their returns on investment and benefit patients.…
Googling the bloodstream: how disease might be detected with ingested nanoparticles Google is developing technology that combines ingested disease-detecting nanoparticles with a wrist sensor.…
We must be there for those who are victims of abuseThe legacy of abuse can stay with victims for life, writes Chris Chapman, who heard escaped Westboro Baptist Church member Nate Phelps speak last week.…
Strategies to reduce the use of antibiotics in animals New drugs that could eventually replace or reduce the use of antibiotics in animals are in development to help slow the rise of antibiotic resistance.…
Study upholds use of metformin monotherapy for first-line diabetes treatment Patients recently diagnosed with diabetes who are prescribed metformin monotherapy are less likely to require treatment intensification compared with patients prescribed other oral glucose-lowering medications as a monotherapy.…